The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability
Abstract
Background —In a group of patients admitted for unstable angina, we investigated whether C-reactive protein (CRP) plasma levels remain elevated at discharge and whether persistent elevation is associated with recurrence of instability. Methods and Results —We measured plasma levels of CRP, serum amyloid A protein (SAA), fibrinogen, total cholesterol, and Helicobacter pylori and Chlamydia pneumoniae antibody titers in 53 patients admitted to our coronary care unit for Braunwald class IIIB unstable angina. Blood samples were taken on admission, at discharge, and after 3 months. Patients were followed for 1 year. At discharge, CRP was elevated (>3 mg/L) in 49% of patients; of these, 42% had elevated levels on admission and at 3 months. Only 15% of patients with discharge levels of CRP <3 mg/L but 69% of those with elevated CRP ( P <0.001) were readmitted because of recurrence of instability or new myocardial infarction. New phases of instability occurred in 13% of patients in the lower tertile of CRP (≤2.5 mg/L), in 42% of those in the intermediate tertile (2.6 to 8.6 mg/L), and in 67% of those in the upper tertile (≥8.7 mg/L, P <0.001). The prognostic value of SAA was similar to that of CRP; that of fibrinogen was not significant. Chlamydia pneumoniae but not Helicobacter pylori antibody titers significantly correlated with CRP plasma levels. Conclusions —In unstable angina, CRP may remain elevated for at ≥3 months after the waning of symptoms and is associated with recurrent instability. Elevation of acute-phase reactants in unstable angina could represent a hallmark of subclinical persistent instability or of susceptibility to recurrent instability and, at least in some patients, could be related to chronic Chlamydia pneumoniae infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Self-citationSaikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Unstable angina. A classification.
Braunwald, E. (1989) · Circulation · doi:10.1161/01.cir.80.2.410 · Cited by 1,366
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Mendall, M. A., Patel, P., Ballam, L., Strachan, D., & Northfield, T. C. (1996) · BMJ · doi:10.1136/bmj.312.7038.1061 · Cited by 846
Cited by
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,224
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study
Cesari, M., Penninx, B. W. J. H., Newman, A. B., Kritchevsky, S. B., Nicklas, B. J., Sutton-Tyrrell, K., Rubin, S. M., Ding, J., Simonsick, E. M., Harris, T. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000097109.90783.fc · Cited by 978
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Widespread Coronary Inflammation in Unstable Angina
Buffon, A., Biasucci, L. M., Liuzzo, G., D'Onofrio, G., Crea, F., & Maseri, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012295 · Cited by 922
Self-citationPasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease
Topol, E. J., & Yadav, J. S. (2000) · Circulation · doi:10.1161/01.cir.101.5.570 · Cited by 770
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Pradhan, A. D., Manson, J. E., Rossouw, J. E., Siscovick, D. S., Mouton, C. P., Rifai, N., Wallace, R. B., Jackson, R. D., Pettinger, M. B., & Ridker, P. M. (2002) · JAMA · doi:10.1001/jama.288.8.980 · Cited by 680
Roberts, W. L., Moulton, L., Law, T. C., Farrow, G., Cooper-Anderson, M., Savory, J., & Rifai, N. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.418 · Cited by 652
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., & Christenson, R. H. (2007) · Circulation · doi:10.1161/circulationaha.107.182882 · Cited by 610
Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease
Blankenberg, S., Rupprecht, H. J., Bickel, C., Peetz, D., Hafner, G., Tiret, L., Meyer, J., & for the AtheroGene Investigators (2001) · Circulation · doi:10.1161/hc3701.095949 · Cited by 589
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64051-5 · Cited by 564
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
Hackam, D. G., & Anand, S. S. (2003) · JAMA · doi:10.1001/jama.290.7.932 · Cited by 550
Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
Stenestrand, U. (2001) · JAMA · doi:10.1001/jama.285.4.430 · Cited by 530
High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease
Rifai, N., & Ridker, P. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.403 · Cited by 521
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., Christenson, R. H., NACB COMMITTEE MEMBERS, et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084194 · Cited by 474
Inflammation – Cause or Consequence of Heart Failure or Both?
Van Linthout, S., & Tschöpe, C. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0337-9 · Cited by 465
High-sensitivity C-reactive proteinClinical importance
BASSUK, S., RIFAI, N., & RIDKER, P. (2004) · Current Problems in Cardiology · doi:10.1016/s0146-2806(04)00074-x · Cited by 464
C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan
Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S., Signorini, S., Mocarelli, P., Hester, A., Glazer, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.508465 · Cited by 456
Targeting cardiovascular inflammation: next steps in clinical translation
Lawler, P. R., Bhatt, D. L., Godoy, L. C., Lüscher, T. F., Bonow, R. O., Verma, S., & Ridker, P. M. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa099 · Cited by 443
Brull, D. J., Montgomery, H. E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., Lowe, G. D. O., & Humphries, S. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.094280 · Cited by 408
Coming of Age of C-Reactive Protein: Using Inflammation Markers in Cardiology
Yeh, E. T. H., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000053731.05365.5a · Cited by 403
Abbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor
Di Napoli, M., Papa, F., & Bocola, V. (2001) · Stroke · doi:10.1161/01.str.32.4.917 · Cited by 389
Heeschen, C., Dimmeler, S., Hamm, C. W., Fichtlscherer, S., Boersma, E., Simoons, M. L., & Zeiher, A. M. (2003) · Circulation · doi:10.1161/01.cir.0000065232.57371.25 · Cited by 388
Circulating markers of inflammation and atherosclerosis
Lind, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00012-1 · Cited by 369
C‐reactive protein and coronary heart disease: a critical review
Casas, J. P., Shah, T., Hingorani, A. D., Danesh, J., & Pepys, M. B. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02015.x · Cited by 366
Inflammation in acute myocardial infarction: the good, the bad and the ugly
Matter, M. A., Paneni, F., Libby, P., Frantz, S., Stähli, B. E., Templin, C., Mengozzi, A., Wang, Y.-J., Kündig, T. M., Räber, L., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehad486 · Cited by 357
Mendall, M. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1982 · Cited by 357
Anti-inflammatory and immunomodulatory effects of statins
Blanco-Colio, L. M., Tuñón, J., Martín-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 347
Slade, G. D., Ghezzi, E. M., Heiss, G., Beck, J. D., Riche, E., & Offenbacher, S. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.10.1172 · Cited by 318
Koenig, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.113 · Cited by 315
Brull, D. J., Serrano, N., Zito, F., Jones, L., Montgomery, H. E., Rumley, A., Sharma, P., Lowe, G. D. O., World, M. J., Humphries, S. E., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000084640.21712.9c · Cited by 305
Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302
Cesari, M., Penninx, B. W. J. H., Newman, A. B., Kritchevsky, S. B., Nicklas, B. J., Sutton-Tyrrell, K., Tracy, R. P., Rubin, S. M., Harris, T. B., & Pahor, M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00718-5 · Cited by 302
Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
Weyand, C. M., Fulbright, J. W., Hunder, G. G., Evans, J. M., & Goronzy, J. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1041::aid-anr12>3.0.co;2-7 · Cited by 299
Held, C., White, H. D., Stewart, R. A. H., Budaj, A., Cannon, C. P., Hochman, J. S., Koenig, W., Siegbahn, A., Steg, P. G., Soffer, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005077 · Cited by 291
Atherothrombosis, inflammation, and diabetes
Biondi-Zoccai, G. G. L., Abbate, A., Liuzzo, G., & Biasucci, L. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00088-3 · Cited by 285
Self-citationAcute coronary syndromes: biology
Fuster, V., Fayad, Z. A., & Badimon, J. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90234-9 · Cited by 283
Glaser, R., Selzer, F., Faxon, D. P., Laskey, W. K., Cohen, H. A., Slater, J., Detre, K. M., & Wilensky, R. L. (2005) · Circulation · doi:10.1161/01.cir.0000150335.01285.12 · Cited by 269
Inflammation: A pivotal link between autoimmune diseases and atherosclerosis
Abou-Raya, A., & Abou-Raya, S. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.12.006 · Cited by 264
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Fichtlscherer, S., Breuer, S., & Zeiher, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000143378.58099.8c · Cited by 252
Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E., & Drexler, H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.065 · Cited by 239
Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study
van den Biggelaar, A. H. J., Huizinga, T. W. J., de Craen, A. J. M., Gussekloo, J., Heijmans, B. T., Frölich, M., & Westendorp, R. G. J. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.009 · Cited by 122
Nahrendorf, M., & Swirski, F. K. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv453 · Cited by 95
Metadata
- Authors
- Biasucci, L. M., Liuzzo, G., Grillo, R. L., Caligiuri, G., Rebuzzi, A. G., Buffon, A., Summaria, F., Ginnetti, F., Fadda, G., & Maseri, A.
- Venue
- Circulation
- Published
- 1999-02-23
- Volume
- 99
- Issue
- 7
- Pages
- 855-860
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1971903720
- Cited by
- 582
- References
- 26
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.